225Ac-labeled anti-EGFR antibody drug radioconjugate elicits durable anti-tumor responses in mouse models of colorectal cancer

被引：0
|
作者：
Tikum, F. [1 ]
Henning, N. [1 ]
Doroudi, A. [1 ]
Ketchemen, J. [1 ]
Babeker, H. [1 ]
Njotu, F. [1 ]
Monzer, A. [1 ]
Nwangele, E. [1 ]
Uppalapati, M. [1 ]
Gray, B. [1 ]
Torlakovic, E. [1 ]
Fonge, H. [1 ]
机构：
[1] Univ Saskatchewan, Saskatoon, SK, Canada
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2024年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-674
引用
收藏
页码：S321 / S322
页数：2
相关论文
共 50 条
  • [1] Effectiveness of 225Ac-labeled anti-EGFR radio immunoconjugate in EGFR positive KRAS and BRAF mutant colorectal cancer models
    Tikum, Anjong
    Babeker, Hanan
    Ketchemen, Jessica Pougoue
    Fonge, Humphrey
    Njotu, Fabrice Ngoh
    Nambisan, Anand
    Doroudi, Alireza
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [2] Effectiveness of 225Ac-Labeled Anti-EGFR Radioimmunoconjugate in EGFR-Positive Kirsten Rat Sarcoma Viral Oncogene and BRAF Mutant Colorectal Cancer Models
    Tikum, Anjong Florence
    Ketchemen, Jessica P.
    Doroudi, Alireza
    Nambisan, Anand K.
    Babeker, Hanan
    Njotu, Fabrice Ngoh
    Fonge, Humphrey
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (03) : 402 - 408
  • [3] Therapeutic efficacy of 225Ac-labeled nimotuzumab in a mouse model of EGFR positive KRAS-mutant metastatic colorectal cancer (mCRC)
    Khan, Behlol
    Khan, Musharraf
    Causey, Patrick
    Perron, Randy
    Gendron, Denise
    Karkare, Sharayu
    Parada, Angel C.
    Geyer, Clarence R.
    Fonge, Humphrey
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [4] Anti-tumor and cell cycle responses in KB cells treated with a chimeric anti-EGFR monoclonal antibody in combination with cisplatin
    Prewett, M
    Rockwell, P
    Rose, C
    Goldstein, NI
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1996, 9 (02) : 217 - 224
  • [5] Tumor targeting of a STING agonist with an antibody-drug conjugate elicits potent anti-tumor immune responses
    Cetinbas, Naniye Malli
    Catcott, Kalli
    Avocetien, Kenneth
    Bentley, Keith
    Carter, Tyler
    Chin, Chen-Ni
    Clardy, Susan
    Eitas, Timothy
    Jones, Brian
    Kelleher, Eoin
    Mosher, Rebecca
    Nazzaro, Mark
    Nehilla, Barrett
    Protopopova, Marina
    Shaw, Pamela
    Slocum, Kelly
    Qin, LiuLiang
    Thomas, Josh
    Yang, Liping
    Toader, Dorin
    Damelin, Marc
    Duvall, Jeremy
    Bukhalid, Raghida
    Lowinger, Timothy
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [6] Rigosertib elicits potent anti-tumor responses in colorectal cancer by inhibiting Ras signaling pathway
    Rahmani, Farzad
    Hashemzehi, Milad
    Avan, Amir
    Barneh, Farnaz
    Asgharzadeh, Fereshteh
    Marjaneh, Reyhaneh Moradi
    Soleimani, Atena
    Parizadeh, Mohammadreza
    Ferns, Gordon A.
    Mobarhan, Majid Ghayour
    Ryzhikov, Mikhail
    Afshari, Amir Reza
    Ahmadian, Mohammad Reza
    Giovannetti, Elisa
    Jafari, Mohieddin
    Khazaei, Majid
    Hassanian, Seyed Mahdi
    CELLULAR SIGNALLING, 2021, 85
  • [7] 225Ac-labeled anti-EphA2/EGFR bispecific radioimmunoconjugate prolongs survival of mice bearing triple negative breast cancer xenograft
    Khan, B.
    Solomon, R.
    Alizadeh, E.
    Thiele, N.
    Causey, P.
    Perron, R.
    Gendron, D.
    Wilson, J.
    Behzad, T.
    Vizeacoumar, F.
    Freywald, A.
    Fonge, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S409 - S410
  • [8] The oligoclonal anti-EGFR antibody MM-151 synergizes with trametinib in KRAS wildtype and mutant colorectal cancer models resistant to conventional monoclonal anti-EGFR antibodies
    Landenranta, J.
    Gerami-Moayed, N.
    Burenkova, O.
    Masson, K.
    Raue, A.
    Wainszelbaum, M.
    MacBeath, G.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S131 - S131
  • [9] In vitro responses to EGFR-targeted therapy with the anti-EGFR antibody ICR62 and/or gefitinib in colorectal tumor cells.
    Cunningham, MP
    Marks, C
    Green, M
    Thomas, H
    Fan, Z
    Modjtahedi, H
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9045S - 9045S
  • [10] Primary tumor site and anti-EGFR monoclonal antibody benefit in metastatic colorectal cancer: a meta-analysis
    Li, Dandan
    Fu, Qiang
    Li, Man
    Li, Jun
    Yin, Can
    Zhao, Jin
    Li, Feng
    FUTURE ONCOLOGY, 2017, 13 (12) : 1115 - 1127
12345